High-throughput genomic technology in research and clinical management of breast cancer. Molecular signatures of progression from benign epithelium to metastatic breast cancer
-
* Corresponding author: Ingrid Hedenfalk Ingrid.Hedenfalk@med.lu.se
Breast Cancer Research 2006, 8:213 doi:10.1186/bcr1528
Accesses
- Last 30 days: 48 accesses
- Last 365 days: 450 accesses
- All time: 4040 accesses